Literature DB >> 12401298

Neonatal herpes infection: diagnosis, treatment and prevention.

Andrea M Enright1, Charles G Prober.   

Abstract

Approximately 2000 neonates contract infection due to herpes simplex virus each year in the United States. Although herpes simplex virus type 2 is responsible for most neonatal infections, approximately 30% of infections are caused by herpes simplex virus type 1. Infections are categorized by extent of disease into skin/eye/mouth, central nervous system and disseminated disease categories. Each disease category is responsible for roughly one third of neonatal infections. Mortality is highest in disseminated disease. Morbidity is highest for survivors of central nervous system infection. Treatment with high dose parenteral acyclovir (60 mg/kg/day) for 14-21 days improves outcome. Since most neonatal infections are acquired from contact with infected maternal genital tract secretions, potential preventative strategies include: Caesarean delivery, serologic screening of pregnant women, prophylactic acyclovir and vaccination. The two strategies currently accepted by most obstetricians are Caesarean delivery for women with active lesions or prodromal symptoms and prophylactic acyclovir for women with gestational herpes. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401298     DOI: 10.1016/s1084-2756(02)90115-6

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  20 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections.

Authors:  A Ardizzoni; B Capuccini; M C Baschieri; C F Orsi; F Rumpianesi; S Peppoloni; C Cermelli; M Meacci; A Crisanti; P Steensgaard; E Blasi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-05       Impact factor: 3.267

Review 3.  Risks associated with viral infections during pregnancy.

Authors:  Karen Racicot; Gil Mor
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

Review 4.  Viral infections during pregnancy.

Authors:  Michelle Silasi; Ingrid Cardenas; Ja-Young Kwon; Karen Racicot; Paula Aldo; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2015-01-13       Impact factor: 3.886

5.  Hematogenous vertical transmission of herpes simplex virus type 1 in mice.

Authors:  Javier S Burgos; Carlos Ramirez; Fernando Guzman-Sanchez; Juan M Alfaro; Isabel Sastre; Fernando Valdivieso
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 6.  Neuroimaging of herpesvirus infections in children.

Authors:  Henry J Baskin; Gary Hedlund
Journal:  Pediatr Radiol       Date:  2007-05-22

7.  Current management of Herpes simplex infection in pregnant women and their newborn infants: What's hot and what's not.

Authors: 
Journal:  Paediatr Child Health       Date:  2003-07       Impact factor: 2.253

8.  Current management of Herpes simplex infection in pregnant women and their newborn infants: What's hot and what's not.

Authors: 
Journal:  Can J Infect Dis       Date:  2003-07

9.  Patient satisfaction with care for genital herpes: insights from a global survey.

Authors:  D M Patrick; S L Rosenthal; L R Stanberry; C Hurst; C Ebel
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

Review 10.  Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention.

Authors:  Elena Anzivino; Daniela Fioriti; Monica Mischitelli; Anna Bellizzi; Valentina Barucca; Fernanda Chiarini; Valeria Pietropaolo
Journal:  Virol J       Date:  2009-04-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.